Ponatinib Plus Reduced-intensity Chemotherapy in the First-line Treatment of Adult Patients With Ph+ ALL
Conditions: Acute Lymphoblastic Leukemia, Adult; Ph+ ALL; Newly Diagnosed Intervention: Drug: Ponatinib 15 MG Oral Tablet Sponsors: Institute of Hematology and Blood Transfusion, Czech Republic; CZECRIN - Czech Clinical Research Infrastructure Network Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials